MARC details
000 -LEADER |
fixed length control field |
03995nam a22005417a 4500 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
220222s20222022 xxu||||| |||| 00| 0 eng d |
024 ## - OTHER STANDARD IDENTIFIER |
Standard number or code |
10.1007/s12149-021-01655-y [doi] |
024 ## - OTHER STANDARD IDENTIFIER |
Standard number or code |
10.1007/s12149-021-01655-y [pii] |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
Ovid MEDLINE(R) |
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC) |
PMID |
35119623 |
245 ## - TITLE STATEMENT |
Title |
I-124 PET/CT image-based dosimetry in patients with differentiated thyroid cancer treated with I-131: correlation of patient-specific lesional dosimetry to treatment response. |
251 ## - Source |
Source |
Annals of Nuclear Medicine. 36(3):213-223, 2022 Mar. |
252 ## - Abbreviated Source |
Abbreviated source |
Ann Nucl Med. 36(3):213-223, 2022 Mar. |
252 ## - Abbreviated Source |
Former abbreviated source |
Ann Nucl Med. 2022 Feb 04 |
253 ## - Journal Name |
Journal name |
Annals of nuclear medicine |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Year |
2022 |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Manufacturer |
FY2022 |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Publication date |
2022 Feb 04 |
265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE] |
Publication status |
ppublish |
266 ## - Date added to catalog |
Date added to catalog |
2022-02-22 |
268 ## - Previous citation |
-- |
Annals of Nuclear Medicine. 2022 Feb 04 |
520 ## - SUMMARY, ETC. |
Abstract |
CONCLUSION: By performing retrospective dosimetry calculations for 131I therapy based on 124I PET/CT imaging, we evaluated the correlation of three dosimetric quantities to lesional response. When lesion AD, BED, and EUD values were > 75 Gy, 47% (9/19) of the lesions had a CR or PR. The AD, BED, and EUD values for SD and PD lesions were < 75 Gy. The data presented herein suggest that the greater the lesion AD, BED, and/or EUD, the higher the probability of a therapeutic response to 131I therapy. Copyright (c) 2022. The Author(s) under exclusive licence to The Japanese Society of Nuclear Medicine. |
520 ## - SUMMARY, ETC. |
Abstract |
METHODS: Nineteen lesions in four patients with metastatic differentiated thyroid cancer (DTC) were evaluated. The patients underwent PET/CT imaging at 2 h, 24 h, 48 h, 72 h, and 96 h post administration of ~ 33-65 MBq (0.89-1.76 mCi) of 124I before undergoing 131I therapy. The 124I PET/CT images were used to perform dosimetry calculations for 131I therapy. Lesion dose-rate values were calculated using the time-activity data and integrated over the measured time points to obtain AD and BED. The Geant4 toolkit was used to run Monte Carlo on spheres the same size as the lesions to estimate EUD. The lesion AD, BED, and EUD values were correlated with response data (i.e. change in lesion size pre- and post-therapy): complete response (CR, i.e. disappearance of the lesion), partial response (PR, i.e. any decrease in lesion length), stable disease (SD, i.e., no change in length), and progressive disease (PD, i.e., any increase in length). |
520 ## - SUMMARY, ETC. |
Abstract |
PURPOSE: The objective of this study is to evaluate the lesion absorbed dose (AD), biological effective dose (BED), and equivalent uniform dose (EUD) to clinical-response relationship in lesional dosimetry for 131I therapy. |
520 ## - SUMMARY, ETC. |
Abstract |
RESULTS: The lesion responses were CR and PR (58%, 11/19 lesions), SD (21%, 4/19), and PD (21%, 4/19). For CR and PR lesions, the ADs, BEDs and EUDs were > 75 Gy for 82% (9/11) and < 75 Gy for 18% (2/11). The ADs and BEDs were < 75 Gy for SD and PD lesions. |
546 ## - LANGUAGE NOTE |
Language note |
English |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
*Iodine Radioisotopes |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
*Thyroid Neoplasms |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Humans |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Iodine Radioisotopes/tu [Therapeutic Use] |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Positron Emission Tomography Computed Tomography |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Radiometry/mt [Methods] |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Retrospective Studies |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Thyroid Neoplasms/dg [Diagnostic Imaging] |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Thyroid Neoplasms/dt [Drug Therapy] |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Thyroid Neoplasms/rt [Radiotherapy] |
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME |
Institution |
MedStar Washington Hospital Center |
656 ## - INDEX TERM--OCCUPATION |
Department |
Medicine/Nuclear Medicine |
657 ## - INDEX TERM--FUNCTION |
Medline publication type |
Journal Article |
700 ## - ADDED ENTRY--PERSONAL NAME |
Local Authors |
Garcia, Carlos |
700 ## - ADDED ENTRY--PERSONAL NAME |
Local Authors |
Plyku, Donika |
700 ## - ADDED ENTRY--PERSONAL NAME |
Local Authors |
Van Nostrand, Douglas |
700 ## - ADDED ENTRY--PERSONAL NAME |
Local Authors |
Wu, Di |
790 ## - Authors |
All authors |
Garcia C, Hobbs RF, Plyku D, Sgouros G, Van Nostrand D, Wu D |
856 ## - ELECTRONIC LOCATION AND ACCESS |
DOI |
<a href="https://dx.doi.org/10.1007/s12149-021-01655-y">https://dx.doi.org/10.1007/s12149-021-01655-y</a> |
Public note |
https://dx.doi.org/10.1007/s12149-021-01655-y |
858 ## - ORCID |
ORCID text |
Plyku, Donika |
Orcid |
<a href="http://orcid.org/0000-0001-7305-8834">http://orcid.org/0000-0001-7305-8834</a> |
Name |
http://orcid.org/0000-0001-7305-8834 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Koha item type |
Journal Article |
Item type description |
Article |